de Vries, Elisabeth G. E.
Kist de Ruijter, Laura
Lub-de Hooge, Marjolijn N.
Dierckx, Rudi A.
Elias, Sjoerd G.
Oosting, Sjoukje F.
Article History
First Online: 27 November 2018
Competing interests
: E.G.E.d.V. has served on data safety monitoring boards or advisory boards for Pfizer and Sanofi and has received research funding from Amgen, Chugai, CytomX, Genentech/Roche, Nordic Nanovector, and Regeneron, with all reimbursements and funding made available to her institution (University Medical Center Groningen). The other authors declare no competing interests.